Evaluation of antimalarial activity and toxicity of a new primaquine prodrug.
Plasmodium vivax is the most prevalent of the five species causing malaria in humans. The current available treatment for P. vivax malaria is limited and unsatisfactory due to at least two drawbacks: the undesirable side effects of primaquine (PQ) and drug resistance to chloroquine. Phenylalanine-al...
Main Authors: | Marcelo Gomes Davanço, Anna Caroline Campos Aguiar, Leandro Alves Dos Santos, Elias Carvalho Padilha, Michel Leandro Campos, Cleverton Roberto de Andrade, Luiz Marcos da Fonseca, Jean Leandro Dos Santos, Chung Man Chin, Antoniana Ursine Krettli, Rosangela Gonçalves Peccinini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4136845?pdf=render |
Similar Items
-
Antimalarial chemotherapy. Mechanisms of action, resistance, and new directions in drug discovery
by: Antoniana Ursine Krettli
Published: (2001-11-01) -
Professor Ruth Sonntag Nussenzweig (1928-2018) First steps towards a successful anti-sporozoite vaccine against malaria
by: Antoniana Ursine Krettli -
The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives
by: Antoniana Ursine Krettli
Published: (2009-07-01) -
Protective antibodies in Trypanosoma cruzi infections: detection, functional activity and possible mechanisms of trypomastigote killing in vivo and in vitro
by: Antoniana Ursine Krettli
Published: (1984-01-01) -
Antimalarial chemotherapy with natural products and chemically defined molecules
by: Luzia Helena Carvalho, et al.
Published: (1991-01-01)